全文获取类型
收费全文 | 53355篇 |
免费 | 2967篇 |
国内免费 | 425篇 |
专业分类
耳鼻咽喉 | 530篇 |
儿科学 | 1120篇 |
妇产科学 | 1599篇 |
基础医学 | 6462篇 |
口腔科学 | 1981篇 |
临床医学 | 4278篇 |
内科学 | 14332篇 |
皮肤病学 | 996篇 |
神经病学 | 4458篇 |
特种医学 | 1475篇 |
外科学 | 8266篇 |
综合类 | 337篇 |
一般理论 | 19篇 |
预防医学 | 2838篇 |
眼科学 | 1052篇 |
药学 | 2887篇 |
中国医学 | 145篇 |
肿瘤学 | 3972篇 |
出版年
2023年 | 354篇 |
2022年 | 687篇 |
2021年 | 1675篇 |
2020年 | 932篇 |
2019年 | 1308篇 |
2018年 | 1798篇 |
2017年 | 1148篇 |
2016年 | 1298篇 |
2015年 | 1545篇 |
2014年 | 2119篇 |
2013年 | 2700篇 |
2012年 | 4153篇 |
2011年 | 4184篇 |
2010年 | 2390篇 |
2009年 | 2103篇 |
2008年 | 3579篇 |
2007年 | 3738篇 |
2006年 | 3499篇 |
2005年 | 3417篇 |
2004年 | 3077篇 |
2003年 | 2758篇 |
2002年 | 2390篇 |
2001年 | 574篇 |
2000年 | 444篇 |
1999年 | 496篇 |
1998年 | 436篇 |
1997年 | 389篇 |
1996年 | 338篇 |
1995年 | 320篇 |
1994年 | 268篇 |
1993年 | 205篇 |
1992年 | 251篇 |
1991年 | 198篇 |
1990年 | 201篇 |
1989年 | 179篇 |
1988年 | 132篇 |
1987年 | 126篇 |
1986年 | 134篇 |
1985年 | 125篇 |
1984年 | 114篇 |
1983年 | 103篇 |
1982年 | 121篇 |
1981年 | 96篇 |
1980年 | 94篇 |
1979年 | 62篇 |
1978年 | 64篇 |
1977年 | 61篇 |
1976年 | 50篇 |
1975年 | 42篇 |
1974年 | 34篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
Jose M. Morales Jose Angel Martinez-Flores Manuel Serrano Maria José Castro Francisco Javier Alfaro Florencio García Miguel Angel Martínez Amado Andrés Esther González Manuel Praga Estela Paz-Artal Antonio Serrano 《Journal of the American Society of Nephrology : JASN》2015,26(3):735-745
In the current immunosuppressive therapy era, vessel thrombosis is the most common cause of early graft loss after renal transplantation. The prevalence of IgA anti–β2-glycoprotein I antibodies (IgA-aB2GPI-ab) in patients on dialysis is elevated (>30%), and these antibodies correlate with mortality and cardiovascular morbidity. To evaluate the effect of IgA-aB2GPI-ab in patients with transplants, we followed all patients transplanted from 2000 to 2002 in the Hospital 12 de Octubre prospectively for 10 years. Presence of IgA-aB2GPI-ab in pretransplant serum was examined retrospectively. Of 269 patients, 89 patients were positive for IgA-aB2GPI-ab (33%; group 1), and the remaining patients were negative (67%; group 2). Graft loss at 6 months post-transplant was significantly higher in group 1 (10 of 89 versus 3 of 180 patients in group 2; P=0.002). The most frequent cause of graft loss was thrombosis of the vessels, which was observed only in group 1 (8 of 10 versus 0 of 3 patients in group 2; P=0.04). Multivariate analysis showed that the presence of IgA-aB2GPI-ab was an independent risk factor for early graft loss (P=0.04) and delayed graft function (P=0.04). There were no significant differences regarding patient survival between the two groups. Graft survival was similar in both groups after 6 months. In conclusion, patients with pretransplant IgA-aB2GPI-ab have a high risk of early graft loss caused by thrombosis and a high risk of delayed graft function. Therefore, pretransplant IgA-aB2GPI-ab may have a detrimental effect on early clinical outcomes after renal transplantation. 相似文献
4.
5.
Primary cutaneous anaplastic large cell lymphomas with 6p25.3 rearrangement exhibit particular histological features
下载免费PDF全文
![点击此处可从《Histopathology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
6.
Weiyu Ye Anna Olsson-Brown Robert A. Watson Vincent T. F. Cheung Robert D. Morgan Isar Nassiri Rosalin Cooper Chelsea A. Taylor Umair Akbani Oliver Brain Rubeta N. Matin Nicholas Coupe Mark R. Middleton Mark Coles Joseph J. Sacco Miranda J. Payne Benjamin P. Fairfax 《British journal of cancer》2021,124(10):1661
Background Immune checkpoint blockers (ICBs) activate CD8+ T cells, eliciting both anti-cancer activity and immune-related adverse events (irAEs). The relationship of irAEs with baseline parameters and clinical outcome is unclear.Methods Retrospective evaluation of irAEs on survival was performed across primary (N = 144) and secondary (N = 211) independent cohorts of patients with metastatic melanoma receiving single agent (pembrolizumab/nivolumab—sICB) or combination (nivolumab and ipilimumab—cICB) checkpoint blockade. RNA from pre-treatment and post-treatment CD8+ T cells was sequenced and differential gene expression according to irAE development assessed.Results 58.3% of patients developed early irAEs and this was associated with longer progression-free (PFS) and overall survival (OS) across both cohorts (log-rank test, OS: P < 0.0001). Median survival for patients without irAEs was 16.6 months (95% CI: 10.9–33.4) versus not-reached (P = 2.8 × 10−6). Pre-treatment monocyte and neutrophil counts, but not BMI, were additional predictors of clinical outcome. Differential expression of numerous gene pathway members was observed in CD8+ T cells according to irAE development, and patients not developing irAEs demonstrating upregulated CXCR1 pre- and post-treatment.Conclusions Early irAE development post-ICB is associated with favourable survival in MM. Development of irAEs is coupled to expression of numerous gene pathways, suggesting irAE development in-part reflects baseline immune activation.Subject terms: Immunotherapy, Melanoma 相似文献
7.
A mixed‐method study of effects of a therapeutic play intervention for children on parental anxiety and parents' perceptions of the intervention
下载免费PDF全文
![点击此处可从《Journal of advanced nursing》网站下载免费的PDF全文](/ch/ext_images/free.gif)
8.
9.
10.